Experience in mammalian biopharmaceutical operations.
Across operations, development, commercial, R&D and support functions.
cGMP facilities.
Slough is a multi-product cGMP manufacturing and development facility for Mammalian Biopharmaceuticals. It is our development center of excellence for gene to GMP supply for all molecule types (including complex proteins) as well as product and process validation studies in support of Biological License Applications (Module3) for our mammalian network. The site supports manufacture for early clinical supply (Phase 1 & 2) as well as niche commercial manufacture.
The cGMP facility houses cell banking, production (fermentation and purification) and quality control laboratories. Lonza Slough was the first multi-product licensed contract manufacturing facility to be licensed by the FDA, with its original Establishment License for the production of monoclonal antibodies first granted in 1985.
Mammalian Cell Culture facility
1,000L single-use production bioreactors
Single-use primary recovery depth filtration system
Three Purification suites
Chromatography systems for upto 450mm columns
Post-viral reduction ultra-filtration suite
Buffer preparation facility
Bulk-fill suite
Sustainability